Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myrtus communis buccal tablet versus amitriptyline gel and dexamethasone mouthwash for minor recurrent aphthous stomatitis
IRCT20260912071020N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of amitriptyline and dexamethasone in aphthosis (RAS) (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoint: Change in aphthous ulcer diameter. Started Apr 2026; status: completed.
02
Drugs
amitriptylinedexamethasone
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on IRCT20260912071020N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260912071020N1.